# Tzvia Bader

> Tzvia Bader is the CEO and co-founder of Leal Health (formerly TrialJectory), a New York-based, AI-powered decision support platform that matches cancer patients with FDA-approved treatments and clinical trials. A serial entrepreneur with roughly two decades in tech, she previously led a global business unit at Amdocs and founded startups Vocativ and KIDDOapp before turning to oncology after losing her mother to lymphoma and later facing her own melanoma diagnosis. She built Leal around a simple, insistent idea: patients, not geography or insurance, should decide which treatments they can reach.

- **Role:** CEO & Co-founder at Leal Health
- **Organizations:** Leal Health (formerly TrialJectory), Amdocs, Vocativ, KIDDOapp, NICE Systems, Frutarom Industries, Israeli American Council
- **Nationality:** Israeli-American
- **Education:** MSc, University of Nottingham, UK
- **Known for:** Co-founded and scaled TrialJectory / Leal Health, an AI-powered cancer treatment decision support platform, Grew the platform to help 6,500+ cancer patients understand their treatment options, Raised a reported $53.7M in total funding, including a Series B

## Career timeline

- **pre-2013** — Held senior roles at Frutarom Industries, NICE Systems and Amdocs, where she headed a global business unit responsible for product growth strategy, global sales and marketing
- **2013** — Diagnosed with malignant melanoma, roughly 20 years after losing her mother to Non-Hodgkin lymphoma
- **pre-2017** — Founded and led Vocativ (social analytics / fake-news detection) and KIDDOapp (family scheduling app); COO at talktala
- **2017** — Co-founded TrialJectory in New York to match cancer patients with clinical trials using AI
- **2023** — Company rebrands to Leal Health, expanding to a single point of access to FDA-approved treatments and clinical trials
- **2024** — Raised Series B (~$26M reported in April 2024); launched generative-AI treatment matching and a patient-centric analytics platform

## Achievements

- Co-founded and scaled TrialJectory / Leal Health, an AI-powered cancer treatment decision support platform
- Grew the platform to help 6,500+ cancer patients understand their treatment options
- Raised a reported $53.7M in total funding, including a Series B
- Built a patient-free business model funded by pharmaceutical partners
- Previously led a global business unit at Nasdaq-listed Amdocs
- Founded two prior startups (Vocativ, KIDDOapp)

## Latest updates

- **2024-04** — Leal Health raised a reported ~$26M round (Series B); total funding around $53.7M.
- **2024-01** — Announced use of generative AI to optimize cancer treatment matching for patients.

## Links

- Website: https://leal.health
- LinkedIn: http://www.linkedin.com/in/tzvia-bader-0689a719
- Twitter/X: https://twitter.com/TrialJectory
- Facebook: https://facebook.com/TrialJectory/

---

Profile page: https://yespress.io/tzvia-bader
Published by YesPress — https://yespress.io
Last updated: 2026-07-07